Kamada to supply Israel with its experimental COVID-19 treatment
The company will manufacture the product from convalescent plasma collected by Israeli National Blood Services and additional Israeli medical institutions.
Follow us on GoogleIDF coronavirus ward open in Rambam's underground parking lot, Oct. 2020(photo credit: IDF SPOKESPERSON'S UNIT)ByREUTERSFollow us on Google
